Extended patent protection for PliagisMajor news... I might be wrong but seems to me that Pliagis coming off protection was holding the stock down or acting as a break in their ascent. Despite this, they got partners involved. And now, we know why. Thinking about it, one could have wonder why Taro did partner for a drug coming off patent when their line of business is doing generics and they could have copied them.
Anyway, this news is more than excellent and the stock has a lot of potential. This could rerate a lot higher.
And what the heck, can not hold myself while looking at the handle of another poster. BINGOOOOOOOOOOOOOOOOOOO !!!! We are off to the races...
GLTA